The leading and top-performing cannabis company in the United States, Trulieve Cannabis Corp. (OTCQX: TCNNF) closed the last session around $38.260 after seeing its market cap rise 0.42% to $2.67B.
There have been 69.63M shares of TCNNF stock outstanding with 29.23M shares available for trading. In light of plans to open a new store, TCNNF stock rose.
Where has TCNNF been moving to?
As an American “seed-to-sale” company, Trulieve primarily focuses on domestically grown cannabis. TCNNF is one of the first and largest licensed medical cannabis companies in the State of Florida. All products are cultivated and produced in-house by TCNNF, and then distributed to Trulieve-branded stores (dispensaries) throughout Florida, in addition to directly to patients through home delivery.
TCNNF’s operations in Commonwealth of Massachusetts have been approved by the Massachusetts Cannabis Control Commission, Trulieve announced this week.
- The TCNNF is slated to open its first dispensary in the state on June 3.
- Mayor David Narkewicz will cut the ribbon on the dispensary in Northampton at 3:00 p.m.
- Located on North King Street in Northampton, Massachusetts, 216 North King Street will serve both adult customers and patients requiring medical marijuana.
- June 3, 2021, will be the first day of business for TCNNF’s new store.
What other plans does TCNNF have?
The Massachusetts store opening also represents a launch of the new brands from Trulieve (TCNNF). TCNNF offers a suite of brands built around its brand purpose: Cultivating Human Potential, allowing recreational and medical users alike to experience life to the fullest. Over the next few weeks, TCNNF will roll out the complete product line at the Northampton store.
